Home > Insider Trading > Filing (0001493152-23-016378)

Filing Details

Accession Number:: 0001493152-23-016378
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-05-11 16:05:42
Reporting Period:: 2023-05-08

Accepted Time:: 2023-05-11 16:05:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1759655	Privia Health Group Inc.	PRVA	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1308574	M Alexander Knaster	C/O Pamplona Capital Management Llc 667 Madison Avenue, 22Nd Floor New York NY 10065	No	No	Yes	No
1554913	Pamplona Capital Management, Llc	C/O Pamplona Capital Management Llc 667 Madison Avenue, 22Nd Floor New York NY 10065	No	No	Yes	No
1554914	Pamplona Capital Partners Iii, L.p.	C/O Pamplona Capital Management Llc, 667 Madison Avenue, 22Nd Floor New York NY 10065	No	No	Yes	No
1554942	Pamplona Capital Management, Llp	C/O Pamplona Capital Management Llc 667 Madison Avenue, 22Nd Floor New York NY 10065	No	No	Yes	No
1650903	Ltd Malta Investments Pe Pamplona	C/O Pamplona Capital Management Llc 667 Madison Avenue, 22Nd Floor New York NY 10065	No	No	Yes	No
1844403	C. John Halsted	C/O Pamplona Capital Management Llc 667 Madison Avenue, 22Nd Floor New York NY 10065	No	No	Yes	No
1859731	Ltd Iii Advisors Equity Pamplona	C/O Pamplona Capital Management Llc 667 Madison Avenue, 22Nd Floor New York NY 10065	No	No	Yes	No
1915345	Pamplona Pe Investments Ii, Ltd.	C/O Pamplona Capital Management Llc 667 Madison Avenue, 22Nd Floor New York NY 10065	No	No	Yes	No
1915347	Pamplona Private Equity Carryco Iii, L.p.	C/O Pamplona Capital Management Llc 667 Madison Avenue, 22Nd Floor New York NY 10065	No	No	Yes	No
1915350	Pamplona Equity Carryco Advisors Iii, Ltd.	C/O Pamplona Capital Management Llc 667 Madison Avenue, 22Nd Floor New York NY 10065	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-05-08	17,741,723	$21.62	0	No	4	S	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnotes

Footnotes

This statement is being filed by (i) Pamplona Capital Partners III, L.P. ("PCP III") (ii) Pamplona Equity Advisors III Ltd. ("PEA III"), (iii) Pamplona Private Equity Carryco III, L.P. ("Carryco III"), (iv) Pamplona Equity Carryco Advisors III, Ltd. ("PECA III"), (v) Pamplona PE Investments II, Ltd. ("PE Inv II"), (vi) Pamplona PE Investments Malta Limited ("PE Malta"), (vii) Pamplona Capital Management LLP, (viii) Pamplona Capital Management LLC, (ix) John C. Halsted and (x) Alexander M. Knaster (the foregoing, collectively, the "Reporting Persons").
Pursuant to an underwriting agreement, dated May 4, 2023 (the "Underwriting Agreement"), and in connection with a registered secondary offering and sale of common stock, par value $0.01 per share (the "Common Stock") of Privia Health Group, Inc. (the "Company") by the selling stockholders listed on Schedule I to the Underwriting Agreement, PCP III sold 13,483,709 shares of Common Stock and Carryco III sold 4,258,014 shares of Common Stock at a purchase price of $21.615 per share.
PCP III and Carryco III are controlled by their respective general partners, PEA III and PECA III, which are both owned by PE Inv II, itself owned 100% by Mr. Knaster. PE Malta serves as an investment manager to PCP III. Pamplona Capital Management LLP and Pamplona Capital Management LLC (collectively, the "Pamplona Manager Entities") serve as investment advisors to PE Malta. Messrs. Halsted and Knaster are the principals of the Pamplona Manager Entities. Accordingly, each Reporting Person may be deemed to share beneficial ownership of the securities held of record by PCP III and Carryco III.
Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such person or entity is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.